Publications by authors named "Rafat Abonour"

64Publications

Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell Tumors.

Clin Genitourin Cancer 2020 Oct 8;18(5):e585-e587. Epub 2020 Feb 8.

Division of Hematology and Medical Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2020.01.008DOI Listing
October 2020

High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.

Cancer 2020 03 19;126(6):1202-1207. Epub 2019 Nov 19.

Division of Hematology/Oncology, Indiana University Simon Cancer Center, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32628DOI Listing
March 2020

High-Dose Chemotherapy and Autologous Stem Cell Transplant.

Urol Clin North Am 2019 Aug 14;46(3):439-448. Epub 2019 May 14.

Division of Hematology & Medical Oncology, Melvin & Bren Simon Cancer Center, Indiana University School of Medicine, 535 Barnhill Drive, RT 400, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2019.04.007DOI Listing
August 2019

Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma.

J Clin Oncol 2018 03 30;36(9):859-866. Epub 2018 Jan 30.

Dan T. Vogl, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; David Dingli, Mayo Clinic, Rochester, MN; Robert Frank Cornell, Vanderbilt University Medical Center, Nashville, TN; Carol Ann Huff, Johns Hopkins University, Baltimore, MD; Sundar Jagannath, Tisch Cancer Institute, Mount Sinai School of Medicine; David Kaminetzky, New York University Langone Medical Center; Ajai Chari, Icahn School of Medicine at Mount Sanai, New York, NY; Divaya Bhutani and Jeffrey Zonder, Karmanos Cancer Institute, Wayne State University, Detroit; Craig Cole, University of Michigan, Ann Arbor, MI; Rachid Baz, H. Lee Moffitt Cancer Center and Research Institute, Tampa; James E. Hoffman, Sylvester Cancer Center, University of Miami, Miami, FL; Ajay Nooka, Winship Cancer Institute, Emory University, Atlanta, GA; Joshua Richter and David Siegel, John Theurer Cancer Center at the Hackensack University Medical Center, Hackensack, NJ; Ravi Vij, Washington University School of Medicine, St Louis, MO; Andrzej Jakubowiak, University of Chicago Medical Center, Chicago, IL; Rafat Abonour, Indiana University Cancer Center, Indianapolis, IN; Gary Schiller, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Terri L. Parker, Yale School of Medicine, New Haven, CT; Luciano J. Costa, University of Alabama at Birmingham, Birmingham, AL; Andrew J. Yee, Massachusetts General Hospital Cancer Center, Boston; Michael Kauffman, Sharon Shacham, Jean-Richard Saint-Martin, Carla D. Picklesimer, and Cassandra Choe-Juliak, Karyopharm Therapeutics, Newton, MA; Rafael Fonseca, Scott Van Wier, Gregory Ahmann, Ilsel Lopez, and A. Keith Stewart, Mayo Clinic of Arizona, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5207DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905485PMC
March 2018

Cancer-related loneliness mediates the relationships between social constraints and symptoms among cancer patients.

J Behav Med 2018 04 5;41(2):243-252. Epub 2017 Oct 5.

Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10865-017-9892-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844795PMC
April 2018

Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes.

Clin Lymphoma Myeloma Leuk 2017 09 17;17(9):575-583.e2. Epub 2017 Jun 17.

US Oncology Research, The Woodlands, TX; Medical Oncology/Hematology, Rocky Mountain Cancer Centers, Denver, CO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.06.013DOI Listing
September 2017

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Biol Blood Marrow Transplant 2015 Dec 30;21(12):2039-2051. Epub 2015 Sep 30.

University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757494PMC
December 2015

Disease-free survival following high dose or standard dose therapy in patients with amyloidosis.

Br J Haematol 2016 07 28;174(1):153-5. Epub 2015 Aug 28.

Indiana University School of Medicine, Indianapolis, IN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13656DOI Listing
July 2016

Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics.

Clin Lymphoma Myeloma Leuk 2015 Jun 11;15(6):368-76. Epub 2014 Dec 11.

Cedars-Sinai Comprehensive Cancer Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2014.12.002DOI Listing
June 2015

High-dose chemotherapy for recurrent ovarian germ cell tumors.

J Clin Oncol 2015 Jan 1;33(2):226-7. Epub 2014 Dec 1.

Indiana University School of Medicine; and Indiana University Simon Cancer Center, Indianapolis, IN

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.4325DOI Listing
January 2015

Is it time for preemptive drug treatment of asymptomatic (smoldering) multiple myeloma?

Leuk Lymphoma 2015 Jan 25;56(1):34-41. Epub 2014 Mar 25.

Hematology and Oncology, Beaumont Health System , Royal Oak, MI , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.897702DOI Listing
January 2015

Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.

Biol Blood Marrow Transplant 2013 Jan 11;19(1):161-3. Epub 2012 Aug 11.

Department of Oncology/Hematology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.08.002DOI Listing
January 2013

Observations of second primary malignancy in patients with multiple myeloma.

Clin Lymphoma Myeloma Leuk 2012 Apr 16;12(2):113-7. Epub 2011 Dec 16.

Indiana University Health University Hospital, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.11.003DOI Listing
April 2012

Novel combination treatments targeting chronic myeloid leukemia stem cells.

Clin Lymphoma Myeloma Leuk 2012 Apr 16;12(2):94-105. Epub 2011 Dec 16.

Division of Hematology/Oncology, Department of Medicine, Indiana University, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.10.003DOI Listing
April 2012

A phase I safety study of enzastaurin plus bortezomib in the treatment of relapsed or refractory multiple myeloma.

Am J Hematol 2011 Jul 31;86(7):573-8. Epub 2011 May 31.

The Multiple Myeloma/Waldenstrom's Macroglobulinemia Program, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.22048
Publisher Site
http://dx.doi.org/10.1002/ajh.22048DOI Listing
July 2011

Preclinical activity of a novel multiple tyrosine kinase and aurora kinase inhibitor, ENMD-2076, against multiple myeloma.

Br J Haematol 2010 Aug 15;150(3):313-25. Epub 2010 Jun 15.

Division of Hematology and Oncology, Department of Internal Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2010.08248.xDOI Listing
August 2010

Salvage chemotherapy with high-dose carboplatin and etoposide with peripheral blood stem cell transplant in patients with relapsed pure seminoma.

Am J Clin Oncol 2011 Jun;34(3):286-8

Division of Hematology-Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e3181d6b518DOI Listing
June 2011

Gastrointestinal plasmacytoma presenting as gastrointestinal bleeding.

Clin Lymphoma Myeloma 2008 Oct;8(5):309-11

Division of Hematology and Oncology, Indiana University School of Medicine, Indianapolis 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2008.n.044DOI Listing
October 2008

Antimyeloma effects of a sesquiterpene lactone parthenolide.

Clin Cancer Res 2008 Mar;14(6):1814-22

Hematology and Oncology Division, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1359DOI Listing
March 2008

A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.

Clin Adv Hematol Oncol 2007 Oct;5(10 Suppl 15):7-19, quiz 21-2

Hematology/Oncology Division, University of Pennsylvania Health System, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA,

View Article

Download full-text PDF

Source
http://myeloma.org/pdfs/2007%20Cl%20Adv%20Hem%20Onc-%20A%20P
Web Search
October 2007

High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.

N Engl J Med 2007 Jul;357(4):340-8

Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa067749DOI Listing
July 2007

Hypersensitivity pneumonitis-like syndrome associated with the use of lenalidomide.

Chest 2007 May;131(5):1572-4

Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Indiana University Medical Center, 1481 W Tenth Street, VA 111P-IU, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.06-1734DOI Listing
May 2007

Weekly bortezomib/methylprednisolone is effective and well tolerated in relapsed multiple myeloma.

Clin Lymphoma Myeloma 2006 Sep;7(2):131-4

Indiana University Cancer Center, Indianapolis, IN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.050DOI Listing
September 2006

Decreased homing of retrovirally transduced human bone marrow CD34+ cells in the NOD/SCID mouse model.

Exp Hematol 2006 Apr;34(4):433-42

Department of Microbiology and Immunology, Division of Hematology/Oncology, Indian University School of Medicine, Indianapolis, 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2005.12.014DOI Listing
April 2006

In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells.

Mol Ther 2006 May 19;13(5):1016-26. Epub 2006 Jan 19.

Herman B. Wells Center for Pediatric Research, Department of Pediatrics, The Riley Hospital for Children, 1044 West Walnut Street R4 468, Indianapolis, IN 46202-5525, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2005.11.017DOI Listing
May 2006

Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma.

Leuk Lymphoma 2005 Oct;46(10):1477-87

Bone Marrow and Stem Cell Transplantation Program, Indiana University Medical Center, 1044 West Walnut Street, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190500158466DOI Listing
October 2005

Modulation of in vitro proliferation kinetics and primitive hematopoietic potential of individual human CD34+CD38-/lo cells in G0.

Blood 2005 Apr 21;105(8):3109-16. Epub 2004 Dec 21.

Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-05-1773DOI Listing
April 2005

Impact of modeled microgravity on migration, differentiation, and cell cycle control of primitive human hematopoietic progenitor cells.

Exp Hematol 2004 Aug;32(8):773-81

Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis 46202, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0301472X0400125
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2004.03.014DOI Listing
August 2004

Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide.

J Clin Oncol 2004 Jun;22(11):2155-8

Indiana Cancer Pavilion, 535 Barnhill Dr, RT #473, Indianapolis, IN 46202-5289, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.11.054DOI Listing
June 2004

Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables.

J Clin Oncol 2003 Nov;21(22):4100-4

Division of Hematology-Oncology, Indiana University School of Medicine and Walther Cancer Institute, Indianapolis, IN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.06.067DOI Listing
November 2003

Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies.

Clin Cancer Res 2002 Nov;8(11):3383-93

Bone Marrow and Stem Cell Transplantation Program, Lymphoma Program, and the Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

View Article

Download full-text PDF

Source
November 2002

Treatment of circulating CD34(+) cells with SDF-1alpha or anti-CXCR4 antibody enhances migration and NOD/SCID repopulating potential.

Exp Hematol 2002 Sep;30(9):1061-9

Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0301-472x(02)00880-9DOI Listing
September 2002

Homing efficiency, cell cycle kinetics, and survival of quiescent and cycling human CD34(+) cells transplanted into conditioned NOD/SCID recipients.

Blood 2002 Mar;99(5):1585-93

Department of Medicine, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, 46202-5121, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v99.5.1585DOI Listing
March 2002